S. Jelić

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial

Jacek Jassem, Tadeusz Pieńkowski, A Płużańska et al. · Journal of Clinical Oncology · 2001 · 308 citations

Medicine, Oncology, Pharmacology +17

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

S. Jelić, Georgios C. Sotiropoulos · Annals of Oncology · 2010 · 229 citations

Medicine, Oncology, Surgery +14

Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Kjell Öberg, Göran Åkerström, Guido Rindi et al. · Annals of Oncology · 2010 · 139 citations · Full text

Medicine, Endocrinology, Oncology +14

Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer

Andreas du Bois, Jørn Herrstedt, Anne-Claire Hardy-Bessard et al. · Journal of Clinical Oncology · 2010 · 105 citations · Full text

Medicine, Oncology, Pharmacology +15